Page last updated: 2024-10-29

iohexol and Hematologic Malignancies

iohexol has been researched along with Hematologic Malignancies in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"The hematologic malignancies were acute myeloid leukemia (n = 8), chronic lymphocytic leukemia (n = 2), multiple myeloma (n = 1), and myelodysplastic syndrome (n = 1)."1.3864 multidetector CT findings of influenza A (H1N1) virus in patients with hematologic malignancies. ( Ebrahim, MA; El-Badrawy, A; Zeidan, A, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Badrawy, A1
Zeidan, A1
Ebrahim, MA1

Other Studies

1 other study available for iohexol and Hematologic Malignancies

ArticleYear
64 multidetector CT findings of influenza A (H1N1) virus in patients with hematologic malignancies.
    Acta radiologica (Stockholm, Sweden : 1987), 2012, Volume: 53, Issue:6

    Topics: Adult; Contrast Media; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Influenza A Vi

2012